Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Insulet Corporation (PODD) PT Raised to $58 at Jefferies
August 4, 2017 8:38 AM EDTJefferies raised its price target on Insulet Corporation (NASDAQ: PODD) to $58.00 (from $48.00) while maintaining a Buy rating following the company's 2Q conference call.
The company provided more detail on the plans it announced on July 20 to abandon its distributor Ypsomed and go... More
Insulet Corporation (PODD) PT Raised to $63 at Cowen on 2Q Report; 'Direct Europe Commercialization Drives Sharp Upward Estimate Revisions'
August 4, 2017 6:42 AM EDTCowen raised its price target on Insulet Corporation (NASDAQ: PODD) to $63.00 (from $52.00) while maintaining a Outperform rating, following the company's second quarter earnings report.
Analyst Doug Schenkel notes the company delivered second quarter revenues above consensus projections, despite offering earnings per share results below... More
